1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 3:Neurologic response to IA nicardipine with or without angioplasty
Case* Postbleeding Day Vessel Nicardipine (mg) Vasospasm Post-Treatment Neurologic Examination 2 7 R MCA 3 Mild Yes R ACA 2 Mild 4 7 BA 5 Moderate No 5 4 R ICA 5 Mild Yes L ICA 5 Moderate L Vert 5 Moderate 6 7 L ICA 5 Severe No 7 6 R ICA 5 Moderate No BA 3 Moderate 9 12 R ACA 5 Moderate No L ACA 5 Moderate 10 4 L ICA 5 Moderate Yes 11 6 L MCA Moderate Yes 12 6 R ICA 2 Moderate No L ICA 3 Moderate 13 13 R ICA 5 Moderate L ICA 2.5 Mild 14 11 L Vert 5 Mild No 15 14 L ICA 2.5 Mild No 19 6 R ICA 2 Mild Yes L ACA 4 Severe 20 10 L ACA 4 Severe Yes L MCA 4 Severe R MCA 4 Severe R ACA 4 Severe 21 4 L MCA 3 Mild No L MCA 3 Mild L ACA 3 Mild 6 R ICA 4 Severe No L ICA 2 Mild 22 8 L ICA 2 Mild No L PCA 1 Moderate 23 9 R ACA 3 Mild Yes 24 7 L ICA 4 Mild Yes
Note.—ACA = anterior cerebral artery, BA = basilar artery, MCA = middle cerebral artery, PCA = posterior cerebral artery, Vert = vertebral artery.
* Case 1 involved the use of papaverine and was not included.